| Code | 3076A | ||||||||||
| MA number | 69/0471/12-S | ||||||||||
| Product Form: | aer nau 1x18 g/140 dávok (fľ.HDPE s rozpr.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPE with nebuliser | ||||||||||
| Route of admin.: | Nasal use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.10.2012 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Mometasone_Sandoz_05.2020.doc
|
| PIL: |
PIL_Mometasone_Sandoz 50 mcg_08_2022.pdf
|
| Safety feature | Yes |
| Data update: | 14.05.2020 |
